Business Description
Perpetua Medical AB
ISIN : SE0022726311
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
PERP B.SwedenP750.GermanyPPTMF.USA IPO Date
2015-06-08Description
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 113.96 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.05 | |||||
Interest Coverage | 0.24 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.47 | |||||
Beneish M-Score | 0.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39.1 | |||||
3-Year FCF Growth Rate | 60.4 | |||||
3-Year Book Growth Rate | -31.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.33 | |||||
9-Day RSI | 50.08 | |||||
14-Day RSI | 49.64 | |||||
3-1 Month Momentum % | 3.46 | |||||
6-1 Month Momentum % | -19.14 | |||||
12-1 Month Momentum % | -21.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.28 | |||||
Quick Ratio | 5.13 | |||||
Cash Ratio | 3.12 | |||||
Days Inventory | 46.41 | |||||
Days Sales Outstanding | 77.12 | |||||
Days Payable | 80.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -64.4 | |||||
Shareholder Yield % | -61.61 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.54 | |||||
Operating Margin % | 1.19 | |||||
Net Margin % | 10.41 | |||||
EBITDA Margin % | 22.55 | |||||
FCF Margin % | -52.26 | |||||
OCF Margin % | -33.25 | |||||
ROE % | 15.66 | |||||
ROA % | 4.65 | |||||
ROIC % | 0.56 | |||||
3-Year ROIIC % | 69.45 | |||||
ROC (Joel Greenblatt) % | 37.17 | |||||
ROCE % | 0.91 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 5.7 | |||||
PE Ratio without NRI | 5.7 | |||||
Price-to-Owner-Earnings | 6.47 | |||||
PS Ratio | 1.17 | |||||
PB Ratio | 1.64 | |||||
EV-to-EBIT | 71.11 | |||||
EV-to-EBITDA | 5.45 | |||||
EV-to-Revenue | 1.22 | |||||
EV-to-FCF | -2.51 | |||||
Price-to-GF-Value | 0.94 | |||||
Earnings Yield (Greenblatt) % | 1.42 | |||||
FCF Yield % | -28.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Perpetua Medical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 16.315 | ||
| EPS (TTM) (kr) | 0.611 | ||
| Beta | 2.4583 | ||
| 3-Year Sharpe Ratio | 0.18 | ||
| 3-Year Sortino Ratio | 0.28 | ||
| Volatility % | 45.5 | ||
| 14-Day RSI | 49.64 | ||
| 14-Day ATR (kr) | 0.394213 | ||
| 20-Day SMA (kr) | 3.4565 | ||
| 12-1 Month Momentum % | -21.44 | ||
| 52-Week Range (kr) | 3.01 - 6 | ||
| Shares Outstanding (Mil) | 8.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Perpetua Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Perpetua Medical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-20 | In 118 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 27 days | ||
| General meeting for 2026 | 2026-05-29 10:00 | 3.80 (+0.26%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 3.39 (+0.00%) | ||
| Annual report for 2025 | 2026-04-17 | 3.28 (+3.14%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-20 | 3.80 (-5.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 5.34 (-1.84%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 4.62 (-3.75%) | ||
| General meeting for 2025 | 2025-06-04 10:00 | 4.59 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-16 | 4.54 (+0.00%) |
Show
Entries
Perpetua Medical AB Frequently Asked Questions
What is Perpetua Medical AB(OSTO:PERP B)'s stock price today?
The current price of OSTO:PERP B is kr3.49. The 52 week high of OSTO:PERP B is kr6.00 and 52 week low is kr3.01.
When is next earnings date of Perpetua Medical AB(OSTO:PERP B)?
The next earnings date of Perpetua Medical AB(OSTO:PERP B) is 2026-08-21.
Does Perpetua Medical AB(OSTO:PERP B) pay dividends? If so, how much?
Perpetua Medical AB(OSTO:PERP B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Perpetua Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers